PMcardio receives FDA Breakthrough Device Designation — read the full story
Dr. Hana Hybasek Dzurikova, MRCVS, PGCert MEd
30. July 2024

Dr. Banno Pins Down Subtle STEMI Case Using PMcardio’s OMI AI Model

Dr. Joseph Banno

This case highlighted the limitations of traditional diagnostic methods and led Dr. Banno to explore innovative solutions for cardiac care. This exploration introduced him to the PMcardio tool, an AI-powered clinical decision support system for ECG interpretation.

“One case that significantly impacted my clinical approach involved a 56-year-old man who presented with acute chest pain to the emergency room. The patient had risk factors, including hypertension and a history of smoking. Initial evaluations showed no ST elevations on the ECG, but his troponin levels were markedly elevated.

Dr Joseph Banno md PMcardio Review
PMcardio OMI AI Model indicated a high probability of Occlusion Myocardial Infarction (OMI).


“Running the patient’s ECG through the PMcardio tool indicated a high probability of Occlusion Myocardial Infarction (OMI), which reinforced my clinical suspicion and prompted an immediate intervention. PMcardio alleviates many challenges in diagnosing OMI by providing high-confidence interpretations that can support clinical judgment. This tool not only reduces diagnostic uncertainty but also enhances the accuracy of cardiac assessments.

Dr Joseph Banno md PMcardio Review
Angiographically confirmed Occlusive Myocardial Infarction (OMI).


“I would recommend the tool to other healthcare professionals. Its ability to learn from large datasets and provide reliable diagnostics far surpasses traditional criteria-based systems. PMcardio has the potential to revolutionize cardiac care, facilitating early and accurate intervention for OMI cases.


Armed with the tool, Dr. Banno integrates AI-driven insights into his ECG assessments, advocating for its broader adoption to optimize cardiac care and improve patient outcomes.

Dr. Banno Pins Down Subtle STEMI Case Using PMcardio's OMI AI Model
Dr. Banno Pins Down Subtle STEMI Case Using PMcardio's OMI AI Model

Pin Down Occlusive MI with Certified AI

Dr. Banno Pins Down Subtle STEMI Case Using PMcardio's OMI AI Model
Dr. Banno Pins Down Subtle STEMI Case Using PMcardio's OMI AI Model

Dr. Hana Hybasek Dzurikova, MRCVS, PGCert MEd

Dr. Hana Hybasek Dzurikova, MRCVS, PGCert MEd is a medical educator driving innovation and change in health professions education through technology-enhanced learning.
Dr. Hana Hybasek Dzurikova, MRCVS, PGCert MEd is a medical educator driving innovation and change in health professions education through technology-enhanced learning.
About PMcardio:

PMcardio is the market leader in AI-powered diagnostics, addressing the world’s leading cause of death – cardiovascular diseases. The innovative clinical assistant empowers healthcare professionals to detect up to 40 cardiovascular diseases. In the form of a smartphone application, the certified Class IIb medical device interprets any 12-lead ECG image in under 5 seconds to provide accurate diagnoses and individualized treatment recommendations tailored to each patient.

About Powerful Medical:

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Don't miss these

Powerful Medical Receives FDA Breakthrough Device Designation for PMcardio STEMI AI ECG Model

Powerful Medical, a leader in AI-driven cardiovascular diagnostics, announces that its PMcardio STEMI AI ECG model has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). This designation recognizes PMcardio as a breakthrough technology for the detection of ST-elevation myocardial infarction (STEMI) and STEMI equivalents—a life-threatening cardiac condition requiring immediate intervention.
ACC_2025

Powerful Medical at ACC 2025: Advancing AI in Cardiovascular Care

We are excited to announce that Powerful Medical will be attending the American College of Cardiology (ACC) 2025 Conference, taking place from March 29th – 31st, 2025, in Chicago, IL, USA. Once again, we have a strong presence at the conference, with multiple papers being presented, underscoring our continued leadership in AI-driven cardiovascular diagnostics.

Join 25,000 healthcare professionals who are already taking advantage of AI